Breast Cancer Genomics Company Eyes IPO Tue., May 21, 2013By Greg Hazley Life sciences shop Bioscribe works the PR beat for NanoString, the Seattle genomics company slating an initial public offering. Read Full Story in Subscriber Area Category: Financial PR & Investor Relations Return to May 21, 2013 News Return to Latest News
No comments have been submitted for this story yet.